Indication
dMMR Colorectal Cancer
2 clinical trials
1 product
1 drug
Clinical trial
Phase II, Single Arm Study of Neoadjuvant Dostarlimab (TSR-042) in Stage II and III Deficient Mismatch Repair Colon CancersStatus: Recruiting, Estimated PCD: 2026-04-01
Product
DostarlimabClinical trial
A Phase II Trial of Cadonilimab in Locally Advanced Stage II/III MSI-H/dMMR Colorectal CancerStatus: Recruiting, Estimated PCD: 2024-09-30
Drug
Cadonilimab